Allogeneic stem-cell transplantation in patients with refractory acute leukemia: A long-term follow-up

Bone Marrow Transplantation

Volumn 37, Issue 1, 2006, Pages 45-50

  Oyekunle, A A ^a,b   Kroger N ^a   Zabelina, T ^a   Ayuk, F ^a   Schieder, H ^a   Renges, H ^a   Fehse, N ^a   Waschke, O ^a   Fehse, B ^a   Kabisch, H ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b OBAFEMI AWOLOWO UNIVERSITY TEACHING HOSPITALS COMPLEX   (Nigeria)

Author keywords

Acute leukemia; Allogeneic stem cell transplantation; Refractory

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLAST CELL; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BLAST CRISIS; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 31344432400     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705207     Document Type: Article

References (32)

1. Stockerl-Goldstein KE, Blume KG. Allogeneic haematopoietic cell transplantation for adult patients with acute myeloid leukemia. In: Thomas ED, Blume KG, Forman SJ (eds). Haematopoietic Cell Transplantation, 2nd edn. Blackwell Science Inc.: USA, 1999, pp 823-834.
2. Catovsky D, Hoffbrand AV. Acute leukemia. In: Hoffbrand AV, Lewis SM, Tuddenham EDG (eds). Postgraduate Haematology, 4th edn. Arnold: London, 2001, pp 373-404.
3. Grigg AP, Szer J, Beresford J, Dodds A, Bradstock K, Durrant S et al. Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia. Br J Haematol 1999; 107: 409.
4. Zander AR, Dicke KA, Keating M, Vellekoop L, Culbert S, Spitzer G et al. Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy. Cancer 1985; 56: 1374-1379.
5. Zander AR, Keating M, Dicke KA, Dixon D, Pierce S, Jagannath S et al. A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission. J Clin Oncol 1988; 6: 1548-1557.
6. Forman SJ, Schmidt GM, Nademanee AP, Amylon MD, Chao NJ, Fahey JL et al. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia. J Clin Oncol 1991; 9: 1570-1574.
7. Mehta J, Powles R, Horton C, Milan S, Treleaven J, Tait D et al. Bone marrow transplantation for primary refractory acute leukemia. Bone Marrow Transplant 1994; 14: 415-418.
8. Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C et al. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Haematologica 2002; 87: 52-58.
9. Ferrara F, Palmieri S, Mele G. Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia. Haematologica 2004; 89: 998-1008.
10. Mattsson J, Uzunel M, Remberger M, Ringden O. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versushost disease after allogeneic stem cell transplantation. Transplantation 2001; 71: 433-439.
11. Thiede C, Bornhauser M, Oelschlagel U, Brendel C, Leo R, Daxberger H et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001; 15: 293-302.
12. Zetterquist H, Mattsson J, Uzunel M, Nasman-Bjork I, Svenberg P, Tammik L et al. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia. Bone Marrow Transplant 2000; 25: 843-851.
13. Diez-Martin JL, Llamas P, Gosalvez J, Lopez-Fernandez C, Polo N, de la Fuente MS et al. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI). Haematologica 1998; 83: 408-415.
14. Jolkowska J, Wachowiak J, Lange A, Kwissa M, Witt M. Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology. J Hematother Stem Cell Res 2000; 9: 263-268.
15. Przepiorka D, Weisdorf D, Martin P, Klmgemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
16. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196-1201.
17. Lee EG, George SL, Caligiuri M, Szatrowski TP, Powell BL, Lemke S et al. Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: Results of cancer and leukemia group B study 9420. J Clin Oncol 1999; 17: 2831.
18. List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D et al. Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase. Blood 2002; 100: 1910-1912.
19. Advani R, Saba HI, Tallman MS, Rowe JM, Wiernik PH, Ramek J et al. Treatment of refractory and relapsed acute mylogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (valspodar). Blood 1999; 93: 787-795.
20. Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 2000; 72: 131-133.
21. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292-2302.
22. Xun CQ, McSweeney PA, Boeckh M, Storb RF, Broudy VC, Thompson JA. Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis. Blood 1999; 94: 3273-3276.
23. Platzbecker U, Thiede C, Freiberg-Richter J, Rollig C, Helwig A, Schakel U et al. Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: Stable remission in high-risk acute myeloid leukemia. Bone Marrow Transplant 2001; 27: 543-546.
24. Sauer H, Jehn U, Kolb HJ, Ledderose G, Wilmanns W. Allogeneic bone marrow transplantation in a patient with bone marrow aplasia (Article in German). Internist (Berlin) 1980; 21: 400-405.
25. Jehn U, Heinemann V, Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine. Ann Hematol 1993; 66: 131-134.
26. Whitlock JA, Wells RJ, Hord JD, Janco RL, Greer JP, Gay JC et al. High-dose cytosine arabinoside and etoposide: An effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 1997; 11: 185-189.
27. Huang XJ, Han W, Xu LP, Chen H, Liu DH, Chen YH et al. A novel approach to HLA-mismatched transplantation Beijing Da Xue Xue Bao 2004; 36: 229-233.
28. Dimopoulos MA, Yau JC, Huan SD, Jagannath S, Spitzer G, Spinolo JA et al. Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation. Am J Hematol 1994; 46: 82-86.
29. Dicke KA, McCredie KB, Spitzer G, Zander AR, Peters L, Verma DS et al. Autologous bone marrow transplantation in patients with adult acute leukemia in relapse. Transplantation 1978; 26: 169-173.
30. Dicke KA, Zander AR, Spitzer G, Verma DS, Peters L, Vellekoop L et al. Autologous bone-marrow transplantation in relapsed adult acute leukaemia. Lancet 1979; 10: 514-517.
31. Dicke KA, Zander AR, Spitzer G, Verma DS, Peters L, Vellekoop L et al. Autologous bone marrow transplantation in relapsed adult acute leukemia. Haematol Blood Transfus 1980; 25: 309-320.
32. Dicke KA, Zander AR, Spitzer G, Verma DS, Peters LJ, Vellekoop L et al. Autologous bone marrow transplantation in relapsed adult acute leukemia. Exp Hematol 1979; 7 (Suppl 5): 170-187.